BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5657041)

  • 21. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

  • 22. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
    McCoy JL; Fefer A; Ting RC; Glynn JP
    Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemopoietic stem cells in murine viurs-induced leukemia. I. Spleen colony assays in CBA mice after Rauscher virus infection (author's transl)].
    Seidel HJ
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973; 79(2):123-34. PubMed ID: 4375353
    [No Abstract]   [Full Text] [Related]  

  • 24. Relevance of virus-induced immunodepression to oncogenesis.
    Bendinelli M
    G Batteriol Virol Immunol; 1974; 67(7-12):173-9. PubMed ID: 4478766
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 26. Human immune response to Rauscher leukemia virus.
    Hersh EM; Gutterman JU; Mavligit G; Gschwind CR; Hanna MG
    Hamatol Bluttransfus; 1974; 14():119-28. PubMed ID: 4475656
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukemia in AKR mice. II. Two modes of suppression of in vitro antibody formation by leukemic cells.
    Roman JM; Golub ES
    Cell Immunol; 1978 Oct; 40(2):316-25. PubMed ID: 719762
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative assay of Moloney leukemia virus and Rauscher leukemia virus by immunofluorescence in cell culture.
    Pinkel D; Yoshida K
    Bibl Haematol; 1968; 30():89-91. PubMed ID: 4877329
    [No Abstract]   [Full Text] [Related]  

  • 29. Xenotropic properties of an isolate from murine Rauscher leukemia virus in primates.
    Ablashi DV; Oie HK; Armstrong GR; Didier-Fichet ML; Tronick SR; Heine U; Dalton AJ
    J Med Primatol; 1976; 5(4):223-36. PubMed ID: 63554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of mouse leukemia viruses. V. Hemagglutination-inhibition and indirect hemagglutination tests.
    Witter R; Hunsmann G; Lange J; Schäfer W
    Virology; 1973 Aug; 54(2):346-58. PubMed ID: 4353517
    [No Abstract]   [Full Text] [Related]  

  • 32. INHIBITION BY LIPOPOLYSACCHARIDE (ENDOTOXIN) OF ANTIBODY RESPONSE OF RABBIT TO COMMON ANTIGEN OF ENTEROBACTERIACEAE.
    SUZUKI T; WHANG HY; GORZYNSKI EA; NETER E
    Proc Soc Exp Biol Med; 1964 Dec; 117():785-9. PubMed ID: 14244955
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune reactivity of RBL-3, a nonproducer leukemia induced by Rauscher murine leukemia virus in C57BL/6 mice.
    Chang KS
    J Natl Cancer Inst; 1978 Jul; 61(1):107-12. PubMed ID: 276620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing.
    Oroszlan S; Fisher CL; Stanley TB; Gilden RV
    J Gen Virol; 1970 Jul; 8(1):1-10. PubMed ID: 4990526
    [No Abstract]   [Full Text] [Related]  

  • 35. Assay in the mouse for delayed-type hypersensitivity to murine leukemia virus.
    Peters RL; Donahoe RM; Kelloff GJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1089-95. PubMed ID: 54434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the pathodynamics of proliferative processes in the spleen of NMRI-mice during the early phase of Rauscher leukemia].
    Komitowski D; Goerttler K
    Exp Pathol (Jena); 1974; 9(3):182-90. PubMed ID: 4435093
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
    Tóth FD; Karsai T; Váczi L
    Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological characterization of a low molecular weight polypeptide of murine leukemia virus.
    Tronick SR; Stephenson JR; Aaronson SA
    Virology; 1973 Jul; 54(1):199-206. PubMed ID: 4351609
    [No Abstract]   [Full Text] [Related]  

  • 39. Murine leukemia and its viruses.
    Rich MA
    Natl Cancer Inst Monogr; 1966 Sep; 22():425-37. PubMed ID: 4288565
    [No Abstract]   [Full Text] [Related]  

  • 40. Inheritance of susceptibility and resistance to Rauscher leukaemia virus.
    Tóth FD; Váczi L; Balogh M
    Acta Microbiol Acad Sci Hung; 1973; 20(3):183-9. PubMed ID: 4798829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.